Reata Pharmaceuticals (RETA) Competitor Comparison
We are evaluating the key criteria listed to compare Reata Pharmaceuticals (RETA) against its competitors in the Biotechnology industry.
Market Capitalization
42 / 368Gross Profits
259 / 278Total Revenue
227 / 300EBITDA
306 / 337Free Cashflow
312 / 352Quick Ratio
164 / 357Earnings per Share
336 / 359Dividend yield
0 / 6Total Cash
102 / 358Performance 3 years
49 / 368Performance 5 years
72 / 368Performance 10 years
8 / 368Linearity 3 years
274 / 368Linearity 5 years
292 / 368Linearity 10 years
347 / 368Total Rank
352 / 368Dividend Rank
256 / 368Valuation Rank
352 / 368Piotroski Rank
307 / 368Muliplier Rank
189 / 368Performance 5 years - RETA ranking 72 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.